Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Tsneem H. S. Mbydeen

Tsneem H. S. Mbydeen

Kettering General Hospital, UK

Title: Sub retinal hyper reflective material in chronic myelogenous leukemia in the setting of decreased CSF absorption and possible benign intracranial hypertension

Biography

Biography: Tsneem H. S. Mbydeen

Abstract

Acute and chronic leukemia are associated with ocular signs such as: retinal hemorrhages and Roth spots. Sub Retinal Hyper Reflective Material (SHRM) are reported in Neovascular Age-Related Macular Degeneration (NVAMD) and Central Serous Chorioretinopathy (CSCR). We are presenting a patient with acute leukemia and SHRM.

Description: A 24-year-old man with a medical history of transient hypoglycemia was having blurry vision that started in the left eye and then involved the right as well as 30-lb weight loss over 4 months.

Examination 02/2022                             

                         

                   Visual Acuity

OD

OS

20/70 +1

20/150

Intraocular Pressure

18

16

Anterior Chamber

Deep, no cells, no flare OU

Fundus Examination

Macula

OD

OS

Roth spots Subfoveal deposits

Dot blot hemorrhages OU

         

Magnetic resonance imaging MRI (Figure 2) showed CSF prominence within the optic nerve sheaths, potential flattening of the posterior sclera, no partially empty turcica but the pituitary may have been slightly diminished in size and mild to moderate narrowing of the left transverse/sigmoid dural venous sinus junction. He was started on acetazolamide which was discontinued later as the blurry vision was due to retinal hemorrhages not idiopathic intracranial hypertension. BCR-ABL1 translocation (9; 22) confirmed chronic myelogenous leukemia (CML). The presentation was thought to be due to leukocytosis, hyper viscosity, reduced CSF absorption, benign intracranial hypertension and stasis in the arteries. He was started on dasatinib and hydroxyurea for CML.

Examination 03/2022

                            Visual Acuity

OD

OS

20/40

20/150

                         Intraocular Pressure

10

10

                                                                The rest of the exam was similar to prior.     

Conclusions: SHRM is a novel finding with chronic myelogenous leukemia in the setting of hyper viscosity, reduced CSF absorption and possible benign intracranial hypertension.